mostraligabue
» » Dopamine Receptor Agonists (New Horizons in Therapeutics)

ePub Dopamine Receptor Agonists (New Horizons in Therapeutics) download

by George Poste,Stanley T. Crooke

ePub Dopamine Receptor Agonists (New Horizons in Therapeutics) download
Author:
George Poste,Stanley T. Crooke
ISBN13:
978-0306416545
ISBN:
0306416549
Language:
Publisher:
Springer; 1984 edition (August 1, 1984)
Category:
Subcategory:
Medicine & Health Sciences
ePub file:
1891 kb
Fb2 file:
1629 kb
Other formats:
mobi lit lrf rtf
Rating:
4.1
Votes:
870

Dopamine Receptor Agonists. Series: New Horizons in Therapeutics. Mechanisms of Receptor Regulation. Poste, George, Crooke, Stanley T. (Ed.

Dopamine Receptor Agonists. 1984. 1985.

Dopamine, in addition to its importance as a precursor of norepinephrine, is now known to be an important . Dopamine Receptor Agonists New Horizons in Therapeutics. George Poste, Stanley T. Crooke. Издание: иллюстрированное.

Dopamine, in addition to its importance as a precursor of norepinephrine, is now known to be an important neurotransmitter in regulating functional activities in a number of major organ systems, including the central ner vous system. the cardiovascular system, the kidney, and the gut. Recent advances in our understanding of the functional role of dopamine, its mechanism of action and the pharmacology of dopaminergic agents have occurred on a broad front.

Автор: George Poste; Stanley T. Crooke Название: Dopamine Receptor Agonists Издательство: Springer . There are new chapters on dopamine proteins and on dopamine receptor oligomerization.

2012 Серия: New Horizons in Therapeutics Язык: English Издание: Softcover reprint of Иллюстрации: 15 illustrations, black and white; xxv, 388 p. 15 illus.

oceedings{Poste1984DopamineRA, title {Dopamine Receptor Agonists}, author {George Poste and Stanley T Crooke and Kline Smith}, booktitle {New Horizons in Therapeutics}, year {1984} }. George Poste, Stanley T Crooke, Kline Smith.

These advances have been paralleled by new insights into the contribution of alterations in dopaminergic reg­ ulation in causing disease and the utility of dopamine . File: PDF, 1. 8 MB. Save for later.

These advances have been paralleled by new insights into the contribution of alterations in dopaminergic reg­ ulation in causing disease and the utility of dopamine agonists and an­ tagonists as therapeutic modalities.

Dopamine, in addition to its importance as a precursor of norepinephrine, is now known to be an important neurotransmitter in regulating functional activities in a number of major organ systems, including the central ner- vous system

Dopamine, in addition to its importance as a precursor of norepinephrine, is now known to be an important neurotransmitter in regulating functional activities in a number of major organ systems, including the central ner- vous system.

Canonical Url: ww. avoisier.

Stanley T Crooke (Crooke, Stanley T). used books, rare books and new books. Dopamine Receptor Agonists (New Horizons in Therapeutics): ISBN 9780306416545 (978-0-306-41654-5) Hardcover, Springer, 1984. Lipoxygenases and Their Products. Find all books by 'Stanley T Crooke' and compare prices Find signed collectible books by 'Stanley T Crooke'. ISBN 9780849347054 (978-0-8493-4705-4) Hardcover, CRC Press, 1993. ISBN 9780121978006 (978-0-12-197800-6) Hardcover, Academic Pr, 1991.

A dopamine receptor agonist (DA) is a compound that activates dopamine receptors. There are two families of dopamine receptors, D2-like and D1-like, and they are all G protein-coupled receptors. D1- and D5-receptors belong to the D1-like family and the D2-like family includes D2, D3 and D4 receptors. The DA are used in Parkinson’s disease and, to a lesser extent, to treat depression, hyperprolactinemia and restless leg syndrome.

Dopamine, in addition to its importance as a precursor of norepinephrine, is now known to be an important neurotransmitter in regulating functional activities in a number of major organ systems, including the central ner­ vous system. the cardiovascular system, the kidney, and the gut. Recent advances in our understanding of the functional role of dopamine, its mechanism of action and the pharmacology of dopaminergic agents have occurred on a broad front. The last few years have witnessed significant progress in the identification and classification of central and peripheral dopamine receptors and the factors that affect their responsiveness to inhibitory and stimulatory ligands. These advances have been paralleled by new insights into the contribution of alterations in dopaminergic reg­ ulation in causing disease and the utility of dopamine agonists and an­ tagonists as therapeutic modalities. This volume, the first in a series of publications arising from the annual Smith Kline and French Research Symposium on New Horizons in Therapeutics, provides a comprehensive survey of current research on peripheral dopamine receptors and the physiologic and therapeutic con­ sequences of stimulating pre-and postsynaptic dopamine receptors. Research in dopamine pharmacology mirrors the remarkable ad­ vances that are occurring in the field of pharmacology at large as a con­ sequence of the involvement of an ever-larger number of scientific dis­ ciplines in the study of drug action.